• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用高危酒精复发评分预测戒酒时间少于 6 个月的肝移植候选者的酒精复发。

Prediction of Alcohol Relapse Among Liver Transplant Candidates With Less Than 6 Months of Abstinence Using the High-Risk Alcoholism Relapse Score.

机构信息

Liver Transplant Unit, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Hospital Clínic, University of Barcelona, Barcelona, Spain.

Grup de Recerca en Addiccions Clínic, Red de Trastornos Adictivos, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic, University of Barcelona, Barcelona, Spain.

出版信息

Liver Transpl. 2019 Aug;25(8):1142-1154. doi: 10.1002/lt.25460. Epub 2019 Jun 25.

DOI:10.1002/lt.25460
PMID:30920118
Abstract

The selection of liver transplantation (LT) candidates with alcohol-use disorder (AUD) is influenced by the risk of alcohol relapse (AR) after LT. We aimed to investigate the risk factors of AR after LT and its impact on graft and recipient outcomes. A retrospective study was conducted that included all consecutive patients with AUD undergoing LT from January 2004 to April 2016 (n = 309), excluding patients with alcoholic hepatitis. Odds ratios (ORs) and 95% confidence intervals (CIs) for AR were analyzed by multinomial logistic regression. Cox regression with time-dependent covariates was used to analyze patient survival and graft cirrhosis. There were 70 (23%) patients who presented AR (median follow-up, 68 months), most of them (n = 44, 63%) presenting heavy AR. The probability of heavy AR was 2.3%, 7.5%, 12%, and 29% at 1, 3, 5, and 10 years after LT, respectively. The independent risk factors for heavy AR included a High-Risk Alcoholism Relapse (HRAR) score ≥3 (OR, 2.39; 95% CI, 1.02-5.56; P = 0.04) and the duration of abstinence (months) before LT (OR, 0.81; 95% CI, 0.66-0.98; P = 0.03). In recipients with <6 months of abstinence before LT, the probability of heavy AR after LT was higher in patients with an HRAR score ≥3 than in those with an HRAR score <3 (20%, 36.7%, and 47% versus 6.8%, 12.4%, and 27% at 1, 3, and 5 years, respectively; log-rank 0.013). The risk of graft cirrhosis was increased in patients with heavy AR (hazard ratio, 3.44; 95% CI, 1.58-7.57; P = 0.002) compared with nonrelapsers, with no differences in patient survival. In conclusion, the HRAR score is helpful in identifying the risk of harmful AR after LT in candidates with <6 months of alcohol abstinence without alcoholic hepatitis. These patients could benefit from a longterm integrative patient-centered approach after LT until lifestyle changes are implemented.

摘要

目的

研究肝移植(LT)后酒精复饮(AR)的危险因素及其对移植物和受者结局的影响。

方法

本研究采用回顾性队列研究,纳入了 2004 年 1 月至 2016 年 4 月期间因酒精使用障碍(AUD)接受 LT 的所有连续患者(n=309),排除了酒精性肝炎患者。采用多变量逻辑回归分析 AR 的危险因素。采用时依协变量 Cox 回归分析患者生存和移植物肝硬化情况。

结果

70 例(23%)患者出现 AR(中位随访时间 68 个月),其中大多数(n=44,63%)为重度 AR。LT 后 1、3、5 和 10 年时重度 AR 的概率分别为 2.3%、7.5%、12%和 29%。发生重度 AR 的独立危险因素包括高风险酒精复饮(HRAR)评分≥3(比值比 2.39,95%置信区间 1.02-5.56;P=0.04)和 LT 前的戒酒时间(月)(比值比 0.81,95%置信区间 0.66-0.98;P=0.03)。LT 前戒酒时间<6 个月的受者中,HRAR 评分≥3 者的重度 AR 发生率高于 HRAR 评分<3 者(LT 后 1、3 和 5 年时分别为 20%、36.7%和 47%,6.8%、12.4%和 27%;log-rank P=0.013)。与非复饮者相比,重度 AR 患者的移植物肝硬化风险增加(风险比 3.44,95%置信区间 1.58-7.57;P=0.002),但患者生存率无差异。

结论

对于 LT 前戒酒时间<6 个月且无酒精性肝炎的患者,HRAR 评分有助于识别 LT 后有害 AR 的风险。这些患者可以从 LT 后长期综合的以患者为中心的方法中获益,直到生活方式改变得以实施。

相似文献

1
Prediction of Alcohol Relapse Among Liver Transplant Candidates With Less Than 6 Months of Abstinence Using the High-Risk Alcoholism Relapse Score.使用高危酒精复发评分预测戒酒时间少于 6 个月的肝移植候选者的酒精复发。
Liver Transpl. 2019 Aug;25(8):1142-1154. doi: 10.1002/lt.25460. Epub 2019 Jun 25.
2
A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years.一种预测肝移植后酒精复饮的简易评分:15年间387例患者的结果
Arch Intern Med. 2007 Jun 11;167(11):1183-8. doi: 10.1001/archinte.167.11.1183.
3
Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis.急性酒精性肝炎肝移植患者的生存情况及酒精复发率的荟萃分析。
Langenbecks Arch Surg. 2018 Nov;403(7):825-836. doi: 10.1007/s00423-018-1720-z. Epub 2018 Oct 22.
4
Severe alcoholic relapse after liver transplantation: What consequences on the graft? A study based on liver biopsies analysis.肝移植后严重酒精复饮:对移植物有何影响?一项基于肝活检分析的研究。
Liver Transpl. 2016 Jun;22(6):773-84. doi: 10.1002/lt.24425.
5
Liver transplantation and alcoholic liver disease: History, controversies, and considerations.肝移植与酒精性肝病:历史、争议与思考。
World J Gastroenterol. 2018 Jul 14;24(26):2785-2805. doi: 10.3748/wjg.v24.i26.2785.
6
Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication.肝移植后严重酒精性复发中的复发性酒精性肝硬化:一种常见且严重的并发症。
Am J Gastroenterol. 2015 Aug;110(8):1160-6; quiz 1167. doi: 10.1038/ajg.2015.204. Epub 2015 Jul 14.
7
Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models.酒精性肝病肝移植受者的饮酒行为:复发预测模型的比较评估。
Transplantation. 2024 Mar 1;108(3):742-749. doi: 10.1097/TP.0000000000004800. Epub 2023 Oct 30.
8
Long-term survival and predictors of relapse and survival after liver transplantation for alcoholic liver disease.酒精性肝病肝移植后的长期生存以及复发和生存的预测因素
Scand J Gastroenterol. 2018 Dec;53(12):1553-1561. doi: 10.1080/00365521.2018.1536226.
9
The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation.移植受体肝脏中的急性酒精性肝炎对肝移植术后结局的影响。
Liver Transpl. 2007 Dec;13(12):1728-35. doi: 10.1002/lt.21298.
10
Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.早期肝移植治疗重症酒精性肝炎患者的结局。
Gastroenterology. 2018 Aug;155(2):422-430.e1. doi: 10.1053/j.gastro.2018.04.009. Epub 2018 Apr 12.

引用本文的文献

1
Survival Benefit From Corticosteroids in Severe Alcohol-associated Hepatitis Attributed to Clinical and Treatment Differences in a Large Multicenter Cohort.大型多中心队列中临床和治疗差异导致皮质类固醇对严重酒精性肝炎具有生存获益。
Clin Transl Gastroenterol. 2025 Jan 1;16(1):e00791. doi: 10.14309/ctg.0000000000000791.
2
Psychosocial Assessment and Management-related Issues Among Liver Transplant Recipients.肝移植受者的心理社会评估及管理相关问题
J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101261. doi: 10.1016/j.jceh.2023.07.414. Epub 2023 Jul 28.
3
How to Optimize the Results of Liver Transplantation for Acute-on-Chronic Liver Failure.
如何优化慢性肝衰竭急性发作的肝移植结果。
Life (Basel). 2023 May 10;13(5):1152. doi: 10.3390/life13051152.
4
Assessment of Canadian policies regarding liver transplant candidacy of people who use alcohol, tobacco, cannabis, and opiates.对加拿大关于饮酒、吸烟、使用大麻和阿片类药物者肝脏移植候选资格政策的评估。
Can Liver J. 2020 Nov 17;3(4):372-380. doi: 10.3138/canlivj.2020-0005. eCollection 2020 Fall.
5
An Assessment of the Psychosocial Evaluation for Early Liver Transplantation in Patients With Acute Alcoholic Hepatitis in the Context of Alcohol Use Disorder, a Case-Control Study.酒精使用障碍背景下急性酒精性肝炎患者早期肝移植心理社会评估的病例对照研究
Subst Abuse. 2022 Aug 10;16:11782218221115659. doi: 10.1177/11782218221115659. eCollection 2022.
6
Identification of Quantifiable Predictors of Relapse in Patients with Alcohol-Associated Liver Disease.酒精性肝病患者复发的可量化预测指标的识别
Hepatol Commun. 2021 Mar 13;5(7):1156-1164. doi: 10.1002/hep4.1704. eCollection 2021 Jul.
7
Incidence and Risk Factors of Alcohol Relapse after Liver Transplantation: Analysis of Pre-Transplant Abstinence and Psychosocial Features.肝移植后酒精复饮的发生率及危险因素:移植前戒酒情况与社会心理特征分析
J Clin Med. 2020 Nov 19;9(11):3716. doi: 10.3390/jcm9113716.
8
Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004-2018 Analysis.美国酒精性肝炎作为肝移植病因的增加情况:2004 - 2018年分析
Transplant Direct. 2020 Oct 8;6(11):e612. doi: 10.1097/TXD.0000000000001051. eCollection 2020 Nov.
9
Active Smoking Before Liver Transplantation in Patients with Alcohol Use Disorder: Risk Factors and Outcomes.酒精使用障碍患者肝移植前主动吸烟:危险因素与结局
J Clin Med. 2020 Aug 21;9(9):2710. doi: 10.3390/jcm9092710.